2025 San Francisco Lung Cancer Conference

2025 San Francisco Lung Cancer Conference is organized by Binaytara Foundation (BTF) and will be held from May 16 - 17, 2025 at Grand Hyatt At SFO, South San Francisco, California, United States of America.

Description:
The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with lung cancer. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in molecular testing and targeted-therapies for thoracic oncology. Expert faculty will aim to place the role of diagnostics, biomarkers and different therapeutic agents in clinical context and discuss how to utilize these tests and therapies to effectively contribute to patient care. 

Learning Objectives:
Upon successful completion of this educational activity, participants will be able to:

• Review potentially actionable molecular abnormalities in lung cancer, and the appropriate testing and treatment for actionable alteration.
• Summarize efficacy and toxicities of immune checkpoint inhibitors, targeted therapy, and other chemotherapy agents in management of management of lung cancer.
• Identify the role of perioperative systemic therapy options in curative-intent treatment of NSCLC, including the role of chemotherapy, immune checkpoint inhibitors and targeted therapy.
• Integrate emerging evidence of cutting edge developments in precision oncology into treatment paradigms for treatment of thoracic malignancies.